LRRK2 and Parkinson disease: Therefore, we wanted to further characterize the astrocyte phenotype in PD patients and report here that LRRK2 G2019S and GBA N370S mutant PD patient astrocytes manifest several hallmarks of the disease seen in PD patient brains, including increased reactivity to inflammatory stimulation, increased Ca2+ release from ER and altered polyamine metabolism.